首页> 外文期刊>BMC Geriatrics >The impact of intravenous thrombolysis on outcome of patients with acute ischemic stroke after 90?years old
【24h】

The impact of intravenous thrombolysis on outcome of patients with acute ischemic stroke after 90?years old

机译:静脉溶栓治疗对90岁以后急性缺血性中风患者结局的影响

获取原文
获取外文期刊封面目录资料

摘要

Background Age increases the risk of mortality and poor prognosis following stroke. The benefit of intravenous thrombolysis in very old patients remains uncertain. The purpose of the study was to evaluate the efficacy and safety of thrombolysis in very old patients considering their perfusion-imaging profile. Methods We conducted a retrospective study including patients older than 90 y.o. admitted for an acute ischemic stroke. A computed tomography perfusion-imaging (CTP) was performed in patients who received thrombolysis. Primary outcome was the functional status at 3?months, assessed by the modified Rankin scale (mRS). Secondary outcomes were the rate of hemorrhagic transformations, duration of hospitalization and the rate of death in the first 7?days. Patients receiving thrombolysis were compared with an age-matched group of non-thrombolysed patients. Results 78 patients were included (31?% male, aged 92?±?1.7 y.o). 37 patients received thrombolysis and among them, 30 had CTP with a mismatch. The three months mRS was not significantly different in the two groups (mRS 0–2: 5?% and 7?% in the thrombolysed and non-thrombolysed group, respectively). Hemorrhagic transformations were more frequent in the thrombolysed group (54?% versus 12?%, p =?0.002) and symptomatic intracranial hemorrhage tended to be associated with mRS at three months and death in the first 7?days. Duration of hospitalization was longer in the thrombolysed group (10?days?±?12 versus 7?days?±?9, p =?0.046). Conclusions Patients who received thrombolysis did not have a better functional prognosis than non-thrombolysed patients.
机译:背景年龄会增加卒中后死亡和预后不良的风险。在非常老的患者中静脉溶栓治疗的益处仍然不确定。该研究的目的是评估考虑到其灌注成像特征的老年患者溶栓的疗效和安全性。方法我们进行了一项回顾性研究,其中包括90岁以上的患者。因急性缺血性中风而入院。对接受溶栓治疗的患者进行了计算机断层扫描灌注成像(CTP)。主要结果是通过改良的兰金量表(mRS)评估的3个月时的功能状态。次要结果是出血转化率,住院时间和前7天的死亡率。将接受溶栓的患者与年龄匹配的非溶栓患者进行比较。结果共纳入78例患者(男性占31%,年龄92-±1.7岁)。 37例患者接受了溶栓治疗,其中30例CTP不匹配。两组的三个月的mRS无明显差异(血栓溶解组和非血栓溶解组的mRS 0-2:分别为5%和7%)。溶栓组的出血性转化更为频繁(54 %%对12 %%,p = 0.002),有症状的颅内出血往往在3个月时与mRS相关,在头7天死亡。溶栓组的住院时间更长(10天±±12天与7天±±9天,p = 0.046)。结论接受溶栓治疗的患者的功能预后没有比未溶栓治疗的患者好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号